🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the substance there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.

Service Response and Content Removal

According to TikTok, the platform has removed violative content and banned related keywords and query recommendations. The company said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or injecting at home.

After minutes of entering one community, a seller shared WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.

Item Information and Pricing

Within these communities, messages show black plastic parcels with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious medical dangers”.